These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 31330410)
1. Evaluation of [ Jiang H; Zhang R; Jiang H; Zhang M; Guo W; Feng G; Pan W; Xu H; Wang S Nucl Med Biol; 2019; 72-73():36-44. PubMed ID: 31330410 [TBL] [Abstract][Full Text] [Related]
2. Noninvasive evaluation of Zhang M; Jiang H; Zhang R; Xu H; Jiang H; Pan W; Li X; Wang Y; Wang S Sci Rep; 2018 Dec; 8(1):17832. PubMed ID: 30546057 [TBL] [Abstract][Full Text] [Related]
3. Screening of radiotracer for diagnosis of colorectal cancer liver metastasis based on MACC1-SPON2. Jiang H; Guo W; Huang K; Jiang H; Zhang R; Hu H; Lin X; Wang S Abdom Radiol (NY); 2021 Jul; 46(7):3227-3237. PubMed ID: 33712897 [TBL] [Abstract][Full Text] [Related]
4. Zhang MY; Zhang RJ; Jiang HJ; Jiang H; Xu HL; Pan WB; Wang YQ; Li X Hepatobiliary Pancreat Dis Int; 2019 Apr; 18(2):164-172. PubMed ID: 30850340 [TBL] [Abstract][Full Text] [Related]
5. Using dual-tracer PET to predict the biologic behavior of human colorectal cancer. Wang H; Zhang J; Tian J; Qu B; Li T; Chen Y; Liu J; Wang S J Nucl Med; 2009 Nov; 50(11):1857-64. PubMed ID: 19837754 [TBL] [Abstract][Full Text] [Related]
6. Prediction of tumor biological characteristics in different colorectal cancer liver metastasis animal models using Xu HL; Li M; Zhang RJ; Jiang HJ; Zhang MY; Li X; Wang YQ; Pan WB Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):140-148. PubMed ID: 29571649 [TBL] [Abstract][Full Text] [Related]
7. Interobserver agreement of qualitative analysis and tumor delineation of 18F-fluoromisonidazole and 3'-deoxy-3'-18F-fluorothymidine PET images in lung cancer. Thureau S; Chaumet-Riffaud P; Modzelewski R; Fernandez P; Tessonnier L; Vervueren L; Cachin F; Berriolo-Riedinger A; Olivier P; Kolesnikov-Gauthier H; Blagosklonov O; Bridji B; Devillers A; Collombier L; Courbon F; Gremillet E; Houzard C; Caignon JM; Roux J; Aide N; Brenot-Rossi I; Doyeux K; Dubray B; Vera P J Nucl Med; 2013 Sep; 54(9):1543-50. PubMed ID: 23918733 [TBL] [Abstract][Full Text] [Related]
8. Monitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinoma. Thézé B; Bernards N; Beynel A; Bouet S; Kuhnast B; Buvat I; Tavitian B; Boisgard R BMC Cancer; 2015 Jul; 15():534. PubMed ID: 26198000 [TBL] [Abstract][Full Text] [Related]
9. Ex-vivo biodistribution and micro-PET/CT imaging of 18F-FDG, 18F-FLT, 18F-FMISO, and 18F-AlF-NOTA-PRGD2 in a prostate tumor-bearing nude mouse model. Cheng Z; Wei R; Wu C; Qing H; Jiang X; Lu H; Chen S; Li X; Xu G; Ai H Nucl Med Commun; 2015 Sep; 36(9):914-21. PubMed ID: 25973694 [TBL] [Abstract][Full Text] [Related]
10. Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971 [TBL] [Abstract][Full Text] [Related]
11. Baseline [(18)F]FMISO μPET as a Predictive Biomarker for Response to HIF-1α Inhibition Combined with 5-FU Chemotherapy in a Human Colorectal Cancer Xenograft Model. De Bruycker S; Vangestel C; Van den Wyngaert T; Wyffels L; Wouters A; Pauwels P; Staelens S; Stroobants S Mol Imaging Biol; 2016 Aug; 18(4):606-16. PubMed ID: 26728163 [TBL] [Abstract][Full Text] [Related]
12. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET. Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312 [TBL] [Abstract][Full Text] [Related]
13. Radiosensitizing effect of irisquinone on glioma through the downregulation of HIF-1α evaluated by 18F-FDG and 18F-FMISO PET/CT. Wang H; Zhang Y; Yu W; Zhao X; Xue Y; Xu H Nucl Med Commun; 2016 Jul; 37(7):705-14. PubMed ID: 26963468 [TBL] [Abstract][Full Text] [Related]
14. Detection of colorectal cancer using ¹⁸F-FLT PET: comparison with ¹⁸F-FDG PET. Yamamoto Y; Kameyama R; Izuishi K; Takebayashi R; Hagiike M; Asakura M; Haba R; Nishiyama Y Nucl Med Commun; 2009 Nov; 30(11):841-5. PubMed ID: 19773672 [TBL] [Abstract][Full Text] [Related]
15. Reproducibility of static and dynamic (18)F-FDG, (18)F-FLT, and (18)F-FMISO MicroPET studies in a murine model of HER2+ breast cancer. Whisenant JG; Peterson TE; Fluckiger JU; Tantawy MN; Ayers GD; Yankeelov TE Mol Imaging Biol; 2013 Feb; 15(1):87-96. PubMed ID: 22644988 [TBL] [Abstract][Full Text] [Related]
16. Micro-positron emission tomography imaging of angiogenesis based on Zhang MY; Jiang HJ; Jiang H; Zhang RJ; Wang ZC Hepatobiliary Pancreat Dis Int; 2021 Aug; 20(4):345-351. PubMed ID: 33753000 [TBL] [Abstract][Full Text] [Related]
17. Potential impact of [18F]3'-deoxy-3'-fluorothymidine versus [18F]fluoro-2-deoxy-D-glucose in positron emission tomography for colorectal cancer. Francis DL; Visvikis D; Costa DC; Arulampalam TH; Townsend C; Luthra SK; Taylor I; Ell PJ Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):988-94. PubMed ID: 12739071 [TBL] [Abstract][Full Text] [Related]
18. Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer. Gu J; Yamamoto H; Fukunaga H; Danno K; Takemasa I; Ikeda M; Tatsumi M; Sekimoto M; Hatazawa J; Nishimura T; Monden M Dig Dis Sci; 2006 Dec; 51(12):2198-205. PubMed ID: 17080242 [TBL] [Abstract][Full Text] [Related]
19. Autoradiographic and small-animal PET comparisons between (18)F-FMISO, (18)F-FDG, (18)F-FLT and the hypoxic selective (64)Cu-ATSM in a rodent model of cancer. Dence CS; Ponde DE; Welch MJ; Lewis JS Nucl Med Biol; 2008 Aug; 35(6):713-20. PubMed ID: 18678357 [TBL] [Abstract][Full Text] [Related]
20. Assessment of biological parameters in head and neck cancer based on in vivo distribution of Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]